Putting money before health is a complete disgrace especially when, with a little lateral thinking, there was a perfect alternative solution to the considerable source of work for the district nurse detailed below
Cell reports
In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
Injections are relatively minor procedures and can be made much more comfortable with simple practices
This makes it a popular choice for those seeking the most direct path to improved energy and mental clarity
So, AOD 9604 should be viewed as a tool for studying metabolism, not as a weight loss treatment